About: PAC-1

An Entity of Type: chemical substance, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

This article refers to the anti-tumor molecule, and not the a2iib3 integrin activation specific antibody of the same name PAC-1 (first procaspase activating compound) is a synthesized chemical compound that selectively induces apoptosis, in cancerous cells. It was granted orphan drug status by the FDA in 2016.

Property	Value
dbo:abstract	This article refers to the anti-tumor molecule, and not the a2iib3 integrin activation specific antibody of the same name PAC-1 (first procaspase activating compound) is a synthesized chemical compound that selectively induces apoptosis, in cancerous cells. It was granted orphan drug status by the FDA in 2016. (en)
dbo:casNumber	315183-21-2
dbo:fdaUniiCode	9LIS8N0B2C
dbo:pubchem	1185541
dbo:thumbnail	wiki-commons:Special:FilePath/PAC-1.svg?width=300
dbo:wikiPageExternalLink	http://vanquishoncology.com http://news.bbc.co.uk/2/hi/health/3670495.stm http://news.bbc.co.uk/2/hi/health/5284850.stm https://clinicaltrials.gov/ct2/show/NCT02355535 https://www.clinicaltrials.gov/ct2/show/NCT02355535 https://www.clinicaltrials.gov/ct2/show/NCT03332355 https://www.clinicaltrials.gov/ct2/show/NCT03927248 https://news.illinois.edu/blog/view/6367/365713 http://news.illinois.edu/news/13/0717cancer_drug_PaulHergenrother_TimFan.html
dbo:wikiPageID	8427461 (xsd:integer)
dbo:wikiPageLength	16118 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID	1043906125 (xsd:integer)
dbo:wikiPageWikiLink	dbr:Cancer dbr:MEK_inhibitor dbr:Johns_Hopkins_University dbr:University_of_Illinois_at_Urbana–Champaign dbc:Programmed_cell_death dbr:Melanoma dbr:Orphan_drug dbr:Chronic_lymphocytic_leukemia dbr:Glioblastoma dbr:Glioma dbc:Experimental_cancer_drugs dbr:Apoptosis dbr:Leukemia dbr:Lymphoma dbr:Zymogen dbr:BRAF_(gene) dbr:Drug_discovery dbc:Cell_signaling dbr:Doxorubicin dbr:Osteosarcoma dbr:Hepatocellular_carcinoma dbr:Temozolomide dbc:Immune_system dbr:Neuroblastoma dbr:Sidney_Kimmel_Comprehensive_Cancer_Center dbr:First_procaspase dbr:Procaspase-3
dbp:c	23 (xsd:integer)
dbp:casNumber	315183 (xsd:integer)
dbp:chemspiderid	12272376 (xsd:integer)
dbp:h	28 (xsd:integer)
dbp:iupacName	2 (xsd:integer)
dbp:iupharLigand	5238 (xsd:integer)
dbp:n	4 (xsd:integer)
dbp:o	2 (xsd:integer)
dbp:pubchem	1185541 (xsd:integer)
dbp:smiles	C=CCc3ccccc3O (en)
dbp:stdinchi	1 (xsd:integer)
dbp:stdinchikey	YQNRVGJCPCNMKT-JLPGSUDCSA-N (en)
dbp:unii	9 (xsd:integer)
dbp:verifiedrevid	451183089 (xsd:integer)
dbp:wikiPageUsesTemplate	dbt:Cite_journal dbt:Drugbox dbt:Refbegin dbt:Refend dbt:Reflist dbt:Cascite dbt:Chemspidercite dbt:Drugbankcite dbt:Fdacite dbt:Stdinchicite
dct:subject	dbc:Programmed_cell_death dbc:Experimental_cancer_drugs dbc:Cell_signaling dbc:Immune_system
gold:hypernym	dbr:Compound
rdf:type	owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 yago:Agent114778436 yago:Antineoplastic102722458 yago:CausalAgent100007347 yago:CytotoxicDrug103157987 yago:Drug103247620 yago:Matter100020827 yago:Medicine103740161 yago:PhysicalEntity100001930 dbo:ChemicalCompound dbo:Drug yago:Substance100020090 yago:WikicatExperimentalCancerDrugs umbel-rc:DrugProduct
rdfs:comment	This article refers to the anti-tumor molecule, and not the a2iib3 integrin activation specific antibody of the same name PAC-1 (first procaspase activating compound) is a synthesized chemical compound that selectively induces apoptosis, in cancerous cells. It was granted orphan drug status by the FDA in 2016. (en)
rdfs:label	PAC-1 (en)
owl:sameAs	freebase:PAC-1 yago-res:PAC-1 wikidata:PAC-1 dbpedia-sh:PAC-1 dbpedia-sr:PAC-1 https://global.dbpedia.org/id/4stq4
prov:wasDerivedFrom	wikipedia-en:PAC-1?oldid=1043906125&ns=0
foaf:depiction	wiki-commons:Special:FilePath/PAC-1.svg
foaf:isPrimaryTopicOf	wikipedia-en:PAC-1
is dbo:wikiPageWikiLink of	dbr:Index_of_immunology_articles dbr:Caspase_3
is foaf:primaryTopic of	wikipedia-en:PAC-1